Steven Keith Burke, SVP, Chief Medical Officer at Akebia Therapeutics, Inc. (AKBA), sold 67,658 shares at $1.39 ($94K) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Scheduled sale ($94k) by SVP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.39 | 20,701 | $29K | 30.6% |
| 2 | $1.39 | 21,582 | $30K | 31.9% |
| 3 | $1.39 | 25,375 | $35K | 37.5% |
| Total | $1.39 avg | 67,658 | $94K | 100% |
| Filing → |
| AKBA | SELL | 2024-05-09 | $31K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $11K | — | Filing → |
| AKBA | SELL | 2024-02-29 | $13K | — | Filing → |